JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
Pegylated Mechano Growth Factor (PEG-MGF) represents a modified variant of the IGF-1 splice variant MGF, engineered with polyethylene glycol conjugation to enhance stability and extend half-life characteristics. This peptide compound serves as a valuable research tool for investigating muscle tissue regeneration pathways, cellular repair mechanisms, and growth factor signaling cascades in controlled laboratory environments. The lyophilized formulation requires precise reconstitution protocols to maintain molecular integrity and ensure reliable experimental outcomes.
Establish sterile working conditions within a laminar flow hood or biosafety cabinet, ensuring all surfaces are thoroughly decontaminated with 70% isopropyl alcohol. Allow the lyophilized PEG-MGF vial to equilibrate to ambient laboratory temperature for approximately 15-20 minutes before initiating reconstitution procedures. This temperature equilibration prevents condensation formation and ensures uniform peptide dissolution.
Examine the lyophilized peptide cake visually, confirming the presence of a white or off-white powder without discoloration, crystallization artifacts, or moisture contamination. Calculate the desired final concentration based on experimental requirements and determine the appropriate solvent volume accordingly.
Step 1: Sanitize the rubber stopper of the PEG-MGF vial thoroughly using alcohol wipes, allowing complete evaporation of residual alcohol before needle insertion.
Step 2: Draw the predetermined volume of bacteriostatic water or sterile distilled water into a sterile syringe, ensuring no air bubbles remain within the syringe barrel.
Step 3: Insert the needle through the rubber stopper at a 45-degree angle, directing the needle tip toward the vial wall rather than directly onto the lyophilized peptide cake.
Step 4: Inject the solvent slowly and steadily against the vial wall, creating a gentle stream that flows down to contact the peptide powder indirectly.
Step 5: Remove the needle and syringe assembly, then gently swirl the vial in circular motions to initiate dissolution without creating excessive foam or turbulence.
Step 6: Allow the solution to stand undisturbed for 2-3 minutes, permitting complete peptide hydration and dissolution.
Step 7: If particulate matter remains visible, continue gentle swirling until complete dissolution occurs. Avoid vigorous shaking or vortexing that may denature the peptide structure.
Step 8: Visually inspect the reconstituted solution for clarity, homogeneity, and absence of precipitates or foreign particles.
The following table presents common reconstitution volumes and resulting concentrations for the 2mg PEG-MGF vial:
Store the reconstituted PEG-MGF solution at 2-8°C under refrigerated conditions for optimal short-term stability. For extended storage periods exceeding one week, prepare single-use aliquots in sterile microcentrifuge tubes and store at -20°C or -80°C to prevent degradation and maintain research integrity.
Avoid repeated freeze-thaw cycles, which may compromise peptide stability and biological activity. Label all storage containers with compound identification, concentration, preparation date, and storage temperature requirements for proper laboratory inventory management.
Element SARMs' PEG-MGF demonstrates excellent solubility characteristics in aqueous solutions, making it suitable for diverse in vitro research applications including cell culture studies, tissue engineering investigations, and molecular biology experiments. The pegylated modification enhances solution stability compared to native MGF variants, providing researchers with extended working timeframes for complex experimental protocols.
Consider preparing working dilutions immediately before experimental use to maintain optimal peptide integrity throughout research procedures. Document all reconstitution parameters, storage conditions, and handling procedures to ensure experimental reproducibility and data quality in laboratory research environments.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
Forgot password?
Country: United States (US-only registration)
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
